<?xml version="1.0"?>
<Articles JournalTitle="Basic &amp; Clinical Cancer Research">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Basic &amp; Clinical Cancer Research</JournalTitle>
      <Issn>2228-6527</Issn>
      <Volume>15</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>01</Month>
        <Day>07</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The diagnostic performance of magnetic resonance imaging (MRI) in the evaluation of breast ultrasound non-mass lesions: a systematic review</title>
    <FirstPage>1</FirstPage>
    <LastPage>8</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Nasrin</FirstName>
        <LastName>Ahmadinejad</LastName>
        <affiliation locale="en_US">Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Medical Imaging Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Golezar</LastName>
        <affiliation locale="en_US">Student Research Committee, Faculty of Medicine, Shahed University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maedeh</FirstName>
        <LastName>Rouzbahani</LastName>
        <affiliation locale="en_US">School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Hassanzadeh</LastName>
        <affiliation locale="en_US">School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Rastkar</LastName>
        <affiliation locale="en_US">Students&#x2019; Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>10</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Aim: The purpose of this study is to conduct a systematic review of the current knowledge regarding the diagnostic performance of MRI in the investigation of non-mass lesions of the breast.
Method: Up to July 2022, PubMed, Scopus, Web of Science, and Embase were searched comprehensively. All studies examining the diagnostic performance of MRI in non-mass lesions were included except review articles, articles published in a language other than English, and case reports or series of cases. A literature review and data extraction were performed by two independent reviewers. A checklist for cross-sectional studies developed by the Joanna Briggs Institute (JBI) was used to assess sources of bias.
&#xD;

Results: The systematic review included two studies. If any enhancement is present on MRI, most ultrasound NMLs will exhibit a non-mass-enhancement. We found that the distribution of non-mass enhancement lesions was primarily segmental and regional. The highest number of malignancies is associated with segmental distributions, since 81.8% of the cases with segmental enhancement were ductal carcinomas, specifically DCIS.
Conclusion: Non-mass lesions of the US that do not enhance in MRI have a good prognosis. Breast cancer is very unlikely in these cases, so follow-up is acceptable unless there is a suspicion of malignancy on mammography. In cases where regional and segmental enhancement of NMLs occurs on CE-MRI, ductal carcinomas may be present, and a pathological examination is warranted.</abstract>
    <web_url>https://bccr.tums.ac.ir/index.php/bccrj/article/view/494</web_url>
  </Article>
</Articles>
